Cargando…
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic
The Coronavirus Disease 2019 (COVID-19) pandemic, a global public health emergency, has changed dermatology practice and daily routine in just under two years. Much has been written in the literature about COVID-19-associated skin manifestations. Nevertheless, much less has been written regarding sk...
Autores principales: | Rosi, Elia, Fastame, Maria Thais, Di Cesare, Antonella, Silvi, Gianmarco, Pimpinelli, Nicola, Prignano, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703332/ https://www.ncbi.nlm.nih.gov/pubmed/34945136 http://dx.doi.org/10.3390/jcm10245841 |
Ejemplares similares
-
Insights into the Pathogenesis of HS and Therapeutical Approaches
por: Rosi, Elia, et al.
Publicado: (2021) -
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits
por: Rosi, Elia, et al.
Publicado: (2022) -
Therapy of PsO in Special Subsets of Patients
por: Di Cesare, Antonella, et al.
Publicado: (2022) -
Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis Suppurativa
por: Rosi, Elia, et al.
Publicado: (2023) -
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?”
por: Di Cesare, Antonella, et al.
Publicado: (2019)